Extravascular implantable cardioverter-defibrillators achieved a successful defibrillation rate of 98.7% at implantation, surpassing the performance goal of 88%.
Does an extravascular implantable cardioverter-defibrillator safely and effectively terminate induced ventricular arrhythmias in patients with an indication for an ICD?
The extravascular ICD system can be safely implanted and effectively detects and terminates ventricular arrhythmias, offering a viable alternative to transvenous and subcutaneous ICDs.
p-value: p=<0.001
In this prospective global study, we found that extravascular ICDs were implanted safely and were able to detect and terminate induced ventricular arrhythmias at the time of implantation. (Funded by Medtronic; ClinicalTrials.gov number, NCT04060680.).
Friedman et al. (Sun,) conducted a other in Cardiac arrhythmias requiring ICD implantation (n=356). Extravascular Implantable Cardioverter–Defibrillator vs. null was evaluated on Successful defibrillation at implantation (95% CI 96.6-100.0, p=<0.001). Extravascular implantable cardioverter-defibrillators achieved a successful defibrillation rate of 98.7% at implantation, surpassing the performance goal of 88%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: